A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness Under the Test-Negative Design: Analysis of Québec Administrative Data

被引:0
|
作者
Jiang, Cong [1 ]
Talbot, Denis [2 ]
Carazo, Sara [3 ]
Schnitzer, Mireille E. [1 ]
机构
[1] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
[2] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada
[3] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada
基金
加拿大健康研究院;
关键词
doubly robust; efficiency bounds; machine learning; outcome-dependent sampling; sample splitting; SENSITIVITY-ANALYSIS; INFLUENZA; CALCULUS; BIAS;
D O I
10.1002/sim.70025
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The test-negative design (TND), which is routinely used for monitoring seasonal flu vaccine effectiveness (VE), has recently become integral to COVID-19 vaccine surveillance, notably in Qu & eacute;bec, Canada. Some studies have addressed the identifiability and estimation of causal parameters under the TND, but efficiency bounds for nonparametric estimators of the target parameter under the unconfoundedness assumption have not yet been investigated. Motivated by the goal of improving adjustment for measured confounders when estimating COVID-19 VE among community-dwelling people aged >= 60$$ \ge 60 $$ years in Qu & eacute;bec, we propose a one-step doubly robust and locally efficient estimator called TNDDR (TND doubly robust), which utilizes cross-fitting (sample splitting) and can incorporate machine learning techniques to estimate the nuisance functions and thus improve control for measured confounders. We derive the efficient influence function (EIF) for the marginal expectation of the outcome under a vaccination intervention, explore the von Mises expansion, and establish the conditions for n$$ \sqrt{n} $$-consistency, asymptotic normality, and double robustness of TNDDR. The proposed estimator is supported by both theoretical and empirical justifications.
引用
收藏
页数:25
相关论文
共 50 条
  • [21] COVID-19 Data Analysis and Appropriate Vaccine Prediction using Machine Learning
    Ullah, Md. Oli
    Nobel, S. M. Nuruzzaman
    2022 IEEE 13TH ANNUAL UBIQUITOUS COMPUTING, ELECTRONICS & MOBILE COMMUNICATION CONFERENCE (UEMCON), 2022, : 496 - 504
  • [22] Use of Recently Vaccinated Individuals to Detect Bias in Test-Negative Case-Control Studies of COVID-19 Vaccine Effectiveness
    Hitchings, Matt D. T.
    Lewnard, Joseph A.
    Dean, Natalie E.
    Ko, Albert I.
    Ranzani, Otavio T.
    Andrews, Jason R.
    Cummings, Derek A. T.
    EPIDEMIOLOGY, 2022, 33 (04) : 450 - 456
  • [23] Effectiveness of COVID-19 Vaccines Over Time Prior to Omicron Emergence in Ontario, Canada: Test-Negative Design Study
    Chung, Hannah
    Austin, Peter C.
    Brown, Kevin A.
    Buchan, Sarah A.
    Fell, Deshayne B.
    Fong, Cindy
    Gubbay, Jonathan B.
    Nasreen, Sharifa
    Schwartz, Kevin L.
    Sundaram, Maria E.
    Tadrous, Mina
    Wilson, Kumanan
    Wilson, Sarah E.
    Kwong, Jeffrey C.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (09):
  • [24] Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors
    Doll, Margaret K.
    Pettigrew, Stacy M.
    Ma, Julia
    Verma, Aman
    CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E564 - E571
  • [25] Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review
    Mesidor, Miceline
    Liu, Yan
    Talbot, Denis
    Skowronski, Danuta M.
    De Serres, Gaston
    Merckx, Joanna
    Koushik, Anita
    Tadrous, Mina
    Carazo, Sara
    Jiang, Cong
    Schnitzer, Mireille E.
    VACCINE, 2024, 42 (05) : 995 - 1003
  • [26] Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study
    Tamada, Yudai
    Takeuchi, Kenji
    Kusama, Taro
    Maeda, Megumi
    Murata, Fumiko
    Osaka, Ken
    Fukuda, Haruhisa
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [27] Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study
    Ranzani, Otavio T.
    Silva, Amanda A. B.
    Peres, Igor T.
    Antunes, Bianca B. P.
    Gonzaga-da-Silva, Thiago W.
    Soranz, Daniel R.
    Cerbino-Neto, Jose
    Hamacher, Silvio
    Bozza, Fernando A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (05) : 736.e1 - 736.e4
  • [28] Bivalent mRNA vaccine effectiveness against COVID-19 among older adults in Japan: a test-negative study from the VENUS study
    Yudai Tamada
    Kenji Takeuchi
    Taro Kusama
    Megumi Maeda
    Fumiko Murata
    Ken Osaka
    Haruhisa Fukuda
    BMC Infectious Diseases, 24
  • [29] Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design
    Fowokan, Adeleke
    Samji, Hasina
    Puyat, Joseph H.
    Janjua, Naveed Z.
    Wilton, James
    Wong, Jason
    Grennan, Troy
    Chambers, Catharine
    Kroch, Abigail
    Costiniuk, Cecilia T.
    Cooper, Curtis L.
    Burchell, Ann N.
    Anis, Aslam
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 127 : 162 - 170
  • [30] Measuring the Effectiveness of COVID-19 Vaccines Used during a Surge of the Delta Variant of SARS-CoV-2 in Bangladesh: A Test-Negative Design Evaluation
    Khanam, Farhana
    Islam, Md Taufiqul
    Ahmmed, Faisal
    Ahmed, Shams Uddin
    Hossen, Md Ismail
    Rajib, MdNazmul Hasan
    Haque, Shahinur
    Biswas, Prasanta Kumar
    Tauheed, Imam
    Zaman, K.
    Alam, Ahmed Nawsher
    Billah, Mallick Masum
    Monalisa, Monalisa
    Ashrafi, Shah Ali Akbar
    Rahman, Mohammed Ziaur
    Bin Manjur, Omar Hamza
    Afrad, Mokibul Hassan
    Shamsuzzaman, S. M.
    Abu Saleh, Ahmed
    Sumon, Mostafa Aziz
    Rashed, Asif
    Bhuiyan, Md Taufiqur Rahman
    Chowdhury, Fahima
    Khan, Ashraful Islam
    Flora, Meerjady Sabrina
    Shirin, Tahmina
    Clemens, John D.
    Qadri, Firdausi
    VACCINES, 2022, 10 (12)